MusclePharm Corporation Debt Instrument, Interest Rate During Period

Prices Discontinued ›Insider Transactions SEC Filings Roast Me Breakdown

Balance Sheet ›Income Statement ›Expense Statement ›Shareholders' Equity ›Cash Flow ›Notes ›

Derivative Liability, Fair Value, Gross Liability Cash, Insured and Uninsured ›and Others ›Inventory, Gross ›and Other Assets ›Property, Plant and Equipment, Disposals Goodwill and Other ›Payables and Accruals ›Restructuring Reserve, Current ASU 2014-09 Transition ›Commitment and Contingencies ›Debt ›Other Liabilities ›Stockholders' Equity Note ›Revenue, Remaining Performance Obligation, Percentage Compensation Related Costs ›Income Taxes ›Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation ›Derivative Instruments and Hedging Activities ›Fair Value Measures and Disclosures ›Leases ›Related Party Transaction, Amounts of Transaction Real Estate Owned, Valuation Allowance, Amounts Applied Valuation and Qualifying Accounts ›Aggregate Indebtedness (Deprecated 2019-01-31)Available-for-sale Securities, Current Cash, Period Increase (Decrease)Due to Related Parties, Current Cover Page ›Increase (Decrease) in Restricted Cash Notes Payable, Related Parties Notes Payable, Related Parties, Current Sales Discounts, Returns and Allowances, Goods (Deprecated 2018-01-31)Trading Securities, Current (Deprecated 2014-01-31)Treasury Stock, Shares Valuation Allowance, Amount (Deprecated 2013-01-31)

Debt Default, Short-term Debt, Amount Line of Credit Facility ›Debt Instruments ›Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net ›

Long-term Debt, Gross Debt Instrument, Face Amount Debt, Long-term and Short-term, Combined Amount Debt Instrument, Interest Rate During Period Debt Instrument, Basis Spread on Variable Rate Debt Instrument, Periodic Payment Debt Instrument, Convertible, Beneficial Conversion Feature Debt Instrument, Convertible, Conversion Price Debt Instrument, Increase (Decrease), Other, Net

MusclePharm Corporation Debt Instrument, Interest Rate During Period

MusclePharm Corporation reported Debt Instrument, Interest Rate During Period of 5.25% for the 1-month period ending 2015-02-28, per its 10-Q filed 2015-11-09.

Discontinued › Notes › Debt › Debt Instruments

us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2015-11-09

2015-02-28: Debt Instrument, Interest Rate During Period 1 month 5.25%.

Period end	Debt Instrument, Interest Rate During Period 1 month
2015-02-28	5.25% 10-Q · filed 2015-11-09